Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Debenture issuance
View:
Post by Pareto8020 on Mar 23, 2023 9:36am

Debenture issuance

Well looks like we found out how they are going to keep the doors open -at least Howie is putting his money where his mouth is for $500k.  So he probably just took his salary from SBM for the last few years and reinvested.

Wonder if this is in relation to how the clinical trial went?  If it went well you'd think they would wait it out in anticipation of shareprice increase.
Comment by lscfa on Mar 23, 2023 9:59am
Why not do a financing after the clinical results when the stock price may be higher?  Bozo mgmt.
Comment by forhandlaren on Mar 23, 2023 11:24am
The answer can be found in this sentence: "Dr. Howard Verrico, the Chief Executive Officer, has agreed to subscribe for $500,000 of Debenture Unit"  Cheap way to increase control of the company - and beneficial at the long term exit that he has expressed as the ultimate goal (buyout).
Comment by lscfa on Mar 23, 2023 11:32am
convertible debentures let the holders participate in any upside potential and get in line ahead of shareholders in the event of insolvency.
Comment by navajojoe on Mar 23, 2023 11:57am
This post has been removed in accordance with Community Policy
Comment by lscfa on Mar 23, 2023 10:19am
genius move..... "We at Sirona Biochem deliberately opted for a higher royalty payment percentage instead of a larger upfront pay,ent. The board and the management made a unanimous decision to structure the agreement this way for the long-term benefit of the company and its shareholders."   "We at Sirona Biochem deliberately opted for a higher royalty payment ...more  
Comment by Pareto8020 on Mar 23, 2023 10:31am
This post has been removed in accordance with Community Policy
Comment by PutinKhuylo1 on Mar 23, 2023 11:24am
Considering Canadian Income Taxes, it would take 6 years of salary lol. As far as anti-aging clinicals are concerned, getting results to monetization are light years apart. In the interim, you have to keep the doors open.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities